(SkyNews) Gucci Ad Banned Over 'Unhealthily Thin' Model

Gucci Ad Banned Over 'Unhealthily Thin' Model
A regulator slams the advert as "irresponsible", but Gucci says nowhere in the ads were any models' "bones" visible.

The ASA found this model appeared 'unhealthily thin' and 'gaunt'
A Gucci advert has been banned by the advertising watchdog because it featured a model who appears "unhealthily thin" and "gaunt".
The advert included two models - one leaning up against a wall in a colourful dress and another in a yellow outfit sitting on a sofa.
A complaint was made about about both, who appeared in stills at the end of a video on The Times website in December 2015.
The Advertising Standards Authority (ASA) upheld the complaint saying the "torso and arms" of the model standing up "were quite slender and appeared to be out of proportion with her head and lower body".
It went on: "Further, her pose elongated her torso and accentuated her waist so that it appeared to be very small.
"We also considered that her sombre facial expression and dark make up, particularly around her eyes, made her face look gaunt.
A complaint was made about both models in the advert
"For those reasons, we considered that the model leaning against the wall appeared to be unhealthily thin in the image, and therefore concluded that the ad was irresponsible."
The Italian fashion house has been told the advert must not appear again in its current form.
Gucci told the ASA the advert was aimed at an older, sophisticated audience and that it felt the model appeared "toned and slim".
It said nowhere in the ads were any models' "bones" visible.
It said their make up was natural and the lighting uniform and warm to ensure there were no hollows caused by shadows and their clothes were not revealing.
Gucci UK told Sky News: "We take our responsibilities as an advertiser very seriously in the way models are selected for and presented in our advertising campaigns.
"We have noted, but are not in agreement with, the assessment of the UK Advertising Standards Authority, an independent regulator, in relation to one model featured in one image from our Cruise 2015 campaign.
"The campaign itself expired at the end of December 2015."

>>> US Early premarket gappers

Early premarket gappers
Gapping up: SUNE +40.7%, APRI +17.6%, DRWI +14.9%, PLCM +10.5%, WLL+3.4%, FCX +3.3%, CHK +2.9%, GFI +2.6%, BCS +2.3%, AZN +2.1%, CRH+1.9%, SHPG +1.8%, RIG +1.7%, GPN +1.7%, OAS +1.6%, CELG +1.4%,CSCO +1.3%, DB +1.2%, CVX +1.2%, GSK +1.1%, NOK +1%, XOM +0.6%

Gapping down: LINE -20.9%, CREE -18.8%, TSM -4.2%, AYI -3.2%, MT-2.9%, HTA -2.5%, DOC -2.4%, DOC -2.4%, HMY -1.9%, STM -1.7%, BHP-1.5%, BBL -1.4%, GDX -1.2%, ABX -1.1%, AGN -1.1%, RIO -1%, WYNN-0.5%

Carrefour Has 4 Blocks Totaling 7.4m Shares Traded at EU23.20/Sh

Carrefour has four blocks of shares traded at EU23.20/share totaling 7.4m shares vs total 1-yr average daily vol of 3.1m in Paris and total of 738.5m shares outstanding.
  • Two blocks of 2.4m shares each, two of 1.3m each traded on BATS Chi-X OTC
Key Shareholdings:
  • Note that on March 30 people familiar with the situation told Bloomberg that Brazilian billionaire Abilio Diniz was considering buying even more shares in Carrefour after boosting his stake Carrefour
    • Earlier on March 30 Diniz family holding Peninsula said in e-mailed statement it increased its Carrefour stake and holds holds 8.05%
  • Moulin family owns 11.51% of Carrefour via holding company Galfa: Feb. filing
  • Bernard Arnault held 8.95% as of Dec. 31, while Colony Capital owned 5.23%: Carrefour website.

>>> S&P 500 in `Most Overbought' Position Since 2009, UBS Says

Last week’s new S&P 500 high is rather an extension of the Feb./March rally and not a new broad-based breakout, UBS technical analysts Michael Riesner and Marc Muller write in note.
  • Market vulnerable to pullback into next week, which UBS would see as beginning of broader and potential distributive tactical top building process
  • On the upside, strong resistance zone at 2080-2090
  • On the downside, re-break below last week’s breakout level at 2056 would be negative into next week; key support remains at 2022
  • Longer term, UBS still sees potential significant pull-back into June/July, towards re-test of key support zone of 1820/1800
  • On sectors, UBS cautious on energy and commodity sectors; health care/biotech are breaking out, which UBS sees as start of a more significant rebound
  • European stock indexes remain weak and continue to trade in its consolidation/pullback pattern of the last 2 weeks
    • Given oversold conditions of European indexes and anticipating the euro to pull back into 2Q, UBS sees potential short-term bounce vs. U.S. market
  • Commodities have started a new tactical down-leg: CRB topped out in late March, with fresh short signal